Helicos Biosciences: Difference between revisions
add note to Firm website. It is inaccessible. |
Removed link to deleted Versant Ventures pages |
||
| Line 1: | Line 1: | ||
'''Helicos BioSciences Corporation''', {{NASDAQ|HLCS}} was a publicly traded [[life science]] company headquartered in [[Cambridge, Massachusetts]] focused on [[genetic analysis]] technologies for the research, drug discovery and diagnostic markets. The firm's Helicos Genetic Analysis Platform was the first DNA-sequencing instrument to operate by [[Single_molecule_fluorescent_sequencing|imaging individual DNA molecules]]. In May 2010, the company announced a 50% layoff and a re-focusing on molecular diagnostics. After long financial troubles, in April 2010, Helicos was delisted from NASDAQ.<ref>{{cite web| url=http://www.bizjournals.com/boston/blog/mass-high-tech/2010/04/helicos-delisting-notice-sends-shares-falling.html | title=Helicos delisting notice sends shares falling | author= | publisher=Boston Business Journal| accessdate=2013-07-29| month=April | year=2010}}</ref> |
'''Helicos BioSciences Corporation''', {{NASDAQ|HLCS}} was a publicly traded [[life science]] company headquartered in [[Cambridge, Massachusetts]] focused on [[genetic analysis]] technologies for the research, drug discovery and diagnostic markets. The firm's Helicos Genetic Analysis Platform was the first DNA-sequencing instrument to operate by [[Single_molecule_fluorescent_sequencing|imaging individual DNA molecules]]. In May 2010, the company announced a 50% layoff and a re-focusing on molecular diagnostics. After long financial troubles, in April 2010, Helicos was delisted from NASDAQ.<ref>{{cite web| url=http://www.bizjournals.com/boston/blog/mass-high-tech/2010/04/helicos-delisting-notice-sends-shares-falling.html | title=Helicos delisting notice sends shares falling | author= | publisher=Boston Business Journal| accessdate=2013-07-29| month=April | year=2010}}</ref> |
||
Helicos was co-founded in 2003 by life science entrepreneur Stanley Lapidus, [[Stephen Quake]], and Noubar Afeyan with investments from [[Atlas Venture]], Flagship Ventures, [[Highland Capital Partners]], [[MPM Capital]], and |
Helicos was co-founded in 2003 by life science entrepreneur Stanley Lapidus, [[Stephen Quake]], and Noubar Afeyan with investments from [[Atlas Venture]], Flagship Ventures, [[Highland Capital Partners]], [[MPM Capital]], and Versant Ventures. |
||
Helicos's technology images the extension of individual DNA molecules using a defined primer and individual fluorescently labeled nucleotides, which contain a "Virtual Terminator"<ref>{{cite web| url=http://www.nature.com/nmeth/journal/v6/n8/abs/nmeth.1354.html | title=Virtual terminator nucleotides for next-generation DNA sequencing | author= | publisher=Nature| accessdate=2013-07-29| month= | year=2009}}</ref> preventing incorporation of multiple nucleotides per cycle. The "Virtual Terminator" technology was developed by Dr. Suhaib Siddiqi,<ref>{{cite web| url=http://www.zsgenetics.com/our-team/ | title=ZS Genetics Team| author= | publisher=| accessdate=2013-07-29| month= | year=}}</ref> while at Helicos Biosciences.<ref>{{cite web| url=http://www.nature.com/nmeth/journal/v6/n8/abs/nmeth.1354.html | title=Virtual terminator nucleotides for next-generation DNA sequencing | author= | publisher=Nature| accessdate=2013-07-29| month= | year=2009}}</ref><ref>{{cite web| url=http://www.freepatentsonline.com/result.html?p=1&sort=relevance&srch=top&query_txt=Suhaib+Siddiqi&patents=on | title=Helicos Virtual Terminators Patents Search Result| author= | publisher=| accessdate=2013-07-29| month= | year=}}</ref> |
Helicos's technology images the extension of individual DNA molecules using a defined primer and individual fluorescently labeled nucleotides, which contain a "Virtual Terminator"<ref>{{cite web| url=http://www.nature.com/nmeth/journal/v6/n8/abs/nmeth.1354.html | title=Virtual terminator nucleotides for next-generation DNA sequencing | author= | publisher=Nature| accessdate=2013-07-29| month= | year=2009}}</ref> preventing incorporation of multiple nucleotides per cycle. The "Virtual Terminator" technology was developed by Dr. Suhaib Siddiqi,<ref>{{cite web| url=http://www.zsgenetics.com/our-team/ | title=ZS Genetics Team| author= | publisher=| accessdate=2013-07-29| month= | year=}}</ref> while at Helicos Biosciences.<ref>{{cite web| url=http://www.nature.com/nmeth/journal/v6/n8/abs/nmeth.1354.html | title=Virtual terminator nucleotides for next-generation DNA sequencing | author= | publisher=Nature| accessdate=2013-07-29| month= | year=2009}}</ref><ref>{{cite web| url=http://www.freepatentsonline.com/result.html?p=1&sort=relevance&srch=top&query_txt=Suhaib+Siddiqi&patents=on | title=Helicos Virtual Terminators Patents Search Result| author= | publisher=| accessdate=2013-07-29| month= | year=}}</ref> |
||
Revision as of 18:47, 29 July 2013
Helicos BioSciences Corporation, Nasdaq: HLCS was a publicly traded life science company headquartered in Cambridge, Massachusetts focused on genetic analysis technologies for the research, drug discovery and diagnostic markets. The firm's Helicos Genetic Analysis Platform was the first DNA-sequencing instrument to operate by imaging individual DNA molecules. In May 2010, the company announced a 50% layoff and a re-focusing on molecular diagnostics. After long financial troubles, in April 2010, Helicos was delisted from NASDAQ.[1]
Helicos was co-founded in 2003 by life science entrepreneur Stanley Lapidus, Stephen Quake, and Noubar Afeyan with investments from Atlas Venture, Flagship Ventures, Highland Capital Partners, MPM Capital, and Versant Ventures.
Helicos's technology images the extension of individual DNA molecules using a defined primer and individual fluorescently labeled nucleotides, which contain a "Virtual Terminator"[2] preventing incorporation of multiple nucleotides per cycle. The "Virtual Terminator" technology was developed by Dr. Suhaib Siddiqi,[3] while at Helicos Biosciences.[4][5]
In the August 2009 issue of Nature Biotechnology, Dr. Stephen Quake, a professor of bioengineering at Stanford University and a co-founder of Helicos BioSciences, sequenced his own genome, using Single Molecule Sequencing for under $50,000 in reagents.[6]
On November 15, 2012, Helicos BioSciences filed for Chapter 11 bankruptcy. [7]
See also
References
- ^ "Helicos delisting notice sends shares falling". Boston Business Journal. 2010. Retrieved 2013-07-29.
{{cite web}}: Unknown parameter|month=ignored (help) - ^ "Virtual terminator nucleotides for next-generation DNA sequencing". Nature. 2009. Retrieved 2013-07-29.
{{cite web}}: Cite has empty unknown parameter:|month=(help) - ^ "ZS Genetics Team". Retrieved 2013-07-29.
{{cite web}}: Cite has empty unknown parameter:|month=(help) - ^ "Virtual terminator nucleotides for next-generation DNA sequencing". Nature. 2009. Retrieved 2013-07-29.
{{cite web}}: Cite has empty unknown parameter:|month=(help) - ^ "Helicos Virtual Terminators Patents Search Result". Retrieved 2013-07-29.
{{cite web}}: Cite has empty unknown parameter:|month=(help) - ^ Daniel MacArthur (2009). "Helicos co-founder sequences own genome using single-molecule technology". Wired. Retrieved 2009-08-10.
{{cite web}}: Unknown parameter|month=ignored (help) - ^ "Helicos Filed Chapter 11 Bankruptcy Form 8-K for HELICOS BIOSCIENCES CORP". Yahoo Finance. 2012. Retrieved 2013-07-29.
{{cite web}}: Unknown parameter|month=ignored (help)
External links
- Helicos BioSciences Corp. firm website (Now defunct after Bankruptcy)
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |